The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8+T Cell Anti-tumor Activity

Authors: Anne Kleijn, Wouter van den Bossche, Erik S. Haefner, Zineb Belcaid, Chantal Burghoorn-Maas, Jenneke J. Kloezeman, Suzan D. Pas, Sieger Leenstra, Reno Debets, Jeroen de Vrij, Clemens M.F. Dirven, Martine L.M. Lamfers

Source: Molecular Therapy: Oncolytics, Vol 5, Iss C, Pp 11-19 (2017)

Subject Terms: glioma, oncolytic virotherapy, adenovirus, immune response, temozolomide, mouse model, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2372770517300050; https://doaj.org/toc/2372-7705

Access URL: https://doaj.org/article/638eb206e27f41b2bcb5dca670a9a6cd

The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells.

Authors: Lotte M E Berghauser Pont, Anne Kleijn, Jenneke J Kloezeman, Wouter van den Bossche, Johanna K Kaufmann, Jeroen de Vrij, Sieger Leenstra, Clemens M F Dirven, Martine L M Lamfers

Source: PLoS ONE, Vol 10, Iss 5, p e0127058 (2015)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: http://europepmc.org/articles/PMC4436250?pdf=render; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/23702382f25b4061a5448aa9022693d4

Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model.

Authors: Hong Jiang, Karen Clise-Dwyer, Kathryn E Ruisaard, Xuejun Fan, Weihua Tian, Joy Gumin, Martine L Lamfers, Anne Kleijn, Frederick F Lang, Wai-Kwan Alfred Yung, Luis M Vence, Candelaria Gomez-Manzano, Juan Fueyo

Source: PLoS ONE, Vol 9, Iss 5, p e97407 (2014)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: http://europepmc.org/articles/PMC4020829?pdf=render; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/fb4673f3b2904821a7d5b9efeabd6a3b

The in vivo therapeutic efficacy of the oncolytic adenovirus Delta24-RGD is mediated by tumor-specific immunity.

Authors: Anne Kleijn, Jenneke Kloezeman, Elike Treffers-Westerlaken, Giulia Fulci, Sieger Leenstra, Clemens Dirven, Reno Debets, Martine Lamfers

Source: PLoS ONE, Vol 9, Iss 5, p e97495 (2014)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: http://europepmc.org/articles/PMC4035348?pdf=render; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/158d9294c950469e912b1fb756c81cee